Only 75 hospitals achieved an “A” grade across all three categories used to determine social responsibility: equity, value and outcomes. None of the top 20 U.S. News & World Report hospitals made the honor roll, despite scoring well for value and outcomes. More
Consumer reviews provide insight into patients' experiences of racism not captured in hospital surveys. More
The FDA approved Alzheimer's drug Aduhelm for all people with mild dementia -- but most of this population is at an increased risk of side effects from the drug. More
Only one California hospital ranked among the 10 most socially responsible hospitals in the United States: Tiny Oroville Hospital, which landed at No. 4 this year on the Lown Institute Hospitals Index. The hospital serves a large number of Medi-Cal beneficiaries and patients with low education levels, according to the report released Tuesday by the Lown Institute, while also excelling at preventing patient errors and re-admissions, keeping mortality rates low and quality clinical outcomes and running an efficient operation. More
The Cleveland Clinic, the second-best hospital in the nation as ranked by U.S. News and World Report, ranks so poorly in equity metrics that it failed to crack the United States' top 500 hospitals when "social responsibility" was taken into account. More
The second annual most socially responsible hospitals rankings are out from the Lown Institute. More
Two Baltimore hospitals — Johns Hopkins Bayview Medical Center and the University of Maryland Medical Center Midtown Campus — have been ranked among the top 10 most “socially responsible” health centers in the U.S. by health care think tank and consulting organization.
More
"We think that hospitals represent really kind of probably the central part, certainly the most visible and the most active part, of all of American healthcare," Lown Institute President Vikas Saini said. "And to get a better healthcare system, hospitals absolutely have to be part of the solution." Saini noted that the individual hospitals on the honor roll were not particularly well-known names. "That was the goal of our whole exercise was to really begin to shine a spotlight on hospitals that might be doing things in a way that hadn't yet been really discovered or recognized," he said. More
Relatively few top healthcare organizations rank high for health equity and social responsibility, a jarring finding considering medicine’s statements committing to health equity over the past year, the Lown Institute reported in a press release sent to journalists. More
The Lown Institute, a nonpartisan healthcare think tank, unveiled the social responsibility ranking Sept. 21. The social responsibility list ranks 3,010 hospitals and is based on 54 metrics across three main categories: equity, value and outcomes. More
The full results of the Lown Hospitals Index reveals which hospitals achieve on equity, outcomes, and value... and which hospitals fall short. More
When the FDA approved new Alzheimer's drug Aduhelm based on little clinical evidence, experts protested. Yet the Aduhelm controversy is just the latest in a pattern of regulators approving new drugs based on surrogate endpoints rather than clinical outcomes that matter to patients. In The BMJ, Jeanne Lenzer and Shannon Brownlee argue that surrogate endpoints provide no guarantee of clinical benefit and should be used only as a last resort in drug trials. More
As orthopedic surgeries have become more prevalent, researchers are taking a closer look at the evidence behind them...or lack thereof. More
Can a policy that was outlawed more than 50 years ago still have an impact today? A recent study on health disparities among residents of formerly "redlined" communities shows the importance of taking a historical view of health equity issues. More
A quirk in the electronic health record system means that it's much harder for clinicians to discontinue medications than prescribe them. More
Recent national data are lacking on the prevalence, safety, and prescribers of opioid prescriptions dispensed to children and young adults aged 0 to 21 years. More
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients. More
Should we even be investing in genetic sequencing for newborns when there is are crises in infant and maternal health that need our attention? More
When researchers, media, and advocates teamed up to bring attention to hospital lawsuits, it led to a dramatic decrease in lawsuits filed. What can we learn from this initiative? More
Over the past 20 years, closing these racial health gaps has become a high priority. What kind of progress have we made? A series of articles in JAMA on health equity paints a sobering picture. More